Pertuzumab and its accelerated approval: evolving treatment paradigms and new challenges in the management of HER2-positive breast cancer.
Year: 2014
Type: article
Source: PubMed
Authors: Ciara C O'Sullivan, Roisin M Connolly
Institutions: Johns Hopkins University, National Institutes of Health
Language: English
Topic: HER2/EGFR in Cancer Research
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W106883867